Results 121 to 130 of about 14,311,182 (307)

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

South Australia [cartographic material]

open access: yes
Map of South Australia showing administrative districts highlighted in different colours; Plate [4] from: Whitehead's Atlas of Australasia. Melbourne : Published by E.
Whitehead & Co.
core  

The VHL tumor suppressor at the crossroad of protein folding, aggregation, and cancer

open access: yesMolecular Oncology, EarlyView.
Mutations, environmental stress, and chaperone dysfunction can destabilize pVHL, promoting its conversion from the native folded state into amyloid‐like assemblies. This transition may contribute to protein storage, cell dormancy, survival, and drug resistance.
Lara Abad   +2 more
wiley   +1 more source

Queensland [cartographic material]

open access: yes
Map of Queensland showing administrative districts highlighted in different colours; Plate [5] from: Whitehead's Atlas of Australasia. Melbourne : Published by E. Whitehead & Co., 1870.; Also available in an electronic version via the internet at: http:/
Whitehead & Co.
core  

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Paclitaxel induces NM2‐dependent cellular contraction through GEF‐H1 dissociation from microtubules and RhoA/ROCK activation in cancer cells

open access: yesMolecular Oncology, EarlyView.
Taxanes are widely used chemotherapeutics whose effects on cellular mechanics remain poorly understood. We show that paclitaxel induces rapid cellular contraction by promoting GEF‐H1 dissociation from microtubules and non‐muscle myosin II activation through RhoA/ROCK.
Gloria Asensio‐Juárez   +5 more
wiley   +1 more source

Route map : Burns, Philp & Co. Ltd. Java-Singapore, China and Pacific Islands services.

open access: yes, 1935
Map of Australasia and South East Asia showing Burns Philp trunk and inter-island services in red.; In bottom right hand corner: K. Craigie & Co., Sydney.; Panel title verso.; Includes advertisement for B.P.
Kenneth Craigie & Co.
core  

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

New and second-hand printing type, material and machinery / F.T. Wimble & Co.

open access: yes, 1900
Electronic reproduction. Canberra, A.C.T. : National Library of Australia, 2010.F.T. Wimble & Co. printing type & materialF.T. Wimble & Co.
F. T. Wimble & Co.
core  

Heritage Society (Houston)

open access: yes
Letter from Fred Herth & Co. to J. H. Brower & Co.
Fred Herth & Co.
core   +2 more sources

Home - About - Disclaimer - Privacy